Tweet
Advisory Notice
Date: 4 July 2008
From: Richard Lloyd, Quality Manager and Office Manager
To: All Customers using the EPFX Electro Physiological Feedback Xrroid in the USA
Re: Advisory Notice
The EPFX Electro Physiological Feedback Xrroid (EPFX) is a registered Class II medical device with the United States Food and Drug Administration (FDA). This means that the device, from its documentation, to its manufacture, to its use, are regulated under the Code of Federal Regulations (CFR)........
To Read the Entire Advisory Notice Click EPFX | Eclosion | Advisory Notice
